---
schema_version: "secwatch.filing_event.v1"
accession: "0001493152-25-021323"
form_type: "8-K"
ticker: "INBS"
cik: "0001725430"
company_name: "INTELLIGENT BIO SOLUTIONS INC."
filed_at: "2025-11-07T23:59:59+00:00"
generated_at: "2026-05-16T23:05:50.356004+00:00"
event_type: "earnings"
sentiment: "positive"
materiality_score: 0.65
calibrated_materiality_score: 0.65
confidence: "high"
source: SEC EDGAR
---

# Intelligent Bio Solutions reports preliminary Q1 FY2026 revenue over $1M, up ~32% sequentially

## Summary
- Preliminary revenue >$1M for fiscal Q1 ended Sep 30, 2025; third consecutive quarter of growth.
- Revenue up ~32% sequentially and ~28% year-over-year.
- Cartridge revenue up ~43% YoY; reader revenue up ~23% YoY.
- Growth driven by new customer accounts and strong sales of both cartridges and readers.
- Full Q1 financial results expected in 10-Q filing week of Nov 10, 2025.

## SEC filing metadata
- accession: 0001493152-25-021323
- form_type: 8-K
- ticker: INBS
- cik: 0001725430
- company_name: INTELLIGENT BIO SOLUTIONS INC.
- filed_at: 2025-11-07T23:59:59+00:00
- event_type: earnings
- sentiment: positive
- materiality_score: 0.65
- calibrated_materiality_score: 0.65
- confidence: high
- sec_items: 2.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1725430/000149315225021323/0001493152-25-021323-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1725430/000149315225021323/form8-k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001493152-25-021323
- JSON: https://secwatch.observer/filing/0001493152-25-021323.json
- Plain text: https://secwatch.observer/filing/0001493152-25-021323.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.